Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse Original Investigations Received: 01 November 1966 DOI:
Cite this article as: Irwin, S. Psychopharmacologia (1968) 13: 222. doi:10.1007/BF00401402 Summary
A systematic observational method is described for comprehensively assessing and quantifying the behavioral and physiologic state of the mouse and its response to drugs. With this method, the pattern profile of various classes of pharmacologic agents and their members can be identified and differentiated, and the relative specificity of their actions defined. The method is applicable to a wide range of investigative goals. Inter- and intra-observer reliability studies have shown it to meet the pragmatic requirements for research.
Key-Words Mouse Animal Behavior Observational Measurement Drugs Biological Assay
The procedure was developed initially at Schering Corp., Bloomfield, N. J. Its further development and revision was supported by grant No. MH 10990 of the National Institutes of Mental Health.
: An introduction to the study of experimental medicine, pp. 89. U.S.A.: Henry Schuman Inc. 1949.
: The effects of meprobamate, barbiturates, d-amphetamine and promazine on experimentally induced conflict in rats. Pharmacologie
, 482–492 (1960).
: Drug screening and evaluative procedures. Science
, 123–128 (1962).
—: Drug screening and evaluation of new compounds in animals. In:
P. E. Siegler
, Eds.: Animal and clinical pharmacologic techniques in drug evaluation. Philadelphia: Year Book Med. Pubs. 1964.
—: Considerations for the pre-clinical evaluation of new psychiatric drugs: A case study with phenothiazine-like tranquilizers. Psychopharmacologia (Berl.)
, 259–287 (1966).
- System analysis: A strategy for drug experimentation and evaluation. Perspectives in Biology and Medicine, 1968 (in press).
S. Slabok, P. L. DeBiase
W. M. Govier
: Perphenazine (Trilafon), a new potent tranquilizer and antiemetic: I. Behavior profile, acute toxicity and behavioral mode of action. Arch. int. Pharmacodyn.
, 358–374 (1959).